GL1X · GenesisL1 explorer

MolNFT v1 · #145087 · protein

Vaccine-elicited HIV-1 neutralizing antibody VFP20.01 in complex with HIV-1 fusion peptide residue 512-519

6CDP · VFP20.01 Fab heavy chain: “Vaccine-elicited HIV-1 neutralizing antibody VFP20.01 in complex with HIV-1 fusion peptide residue 512-519”. X-ray diffraction, 1 ligand (SO4), 3 pockets (best druggability 0.66). MolNFT v1 #145087 on…

PDB
6CDP
Type
protein
Length
448 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VFP20.01 Fab heavy chain; VFP20.01 Fab light chain; HIV-1 fusion peptide 512-519
Ligands
SO4
Pockets
3 · best druggability 0.66

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVFP20.01 Fab heavy chainprotein2217% helix, 51% strand—
BVFP20.01 Fab light chainprotein2196% helix, 50% strand—
CHIV-1 fusion peptide 512-519protein80% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17750.660.7469empty
2990.350.7418empty
3890.330.7324empty

Interfaces

3 interfaces between chains.

  • A–B · 1987 Ų buried · 13 hydrogen bonds · protein-protein
  • A–C · 486 Ų buried · 8 hydrogen bonds · protein-protein
  • B–C · 218 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 6CDP · Vaccine-elicited HIV-1 neutralizing antibody vFP20.01 in complex with HIV-1 fusion… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.